Simon Greaves

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada.

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada.

Journal: Pain

Published: September 02, 2020

Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case-Control Study.

Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case-Control Study.

Journal: Drug safety

Published: April 25, 2020

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.

Journal: JAMA network open

Published: October 17, 2019

Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older-A Population-Based Cohort Study.

Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older-A Population-Based Cohort Study.

Journal: JAMA internal medicine

Published: July 16, 2019

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Journal: Annals of internal medicine

Published: August 25, 2018

Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.

Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.

Journal: The International journal on drug policy

Published: April 30, 2018

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Journal: Journal of addiction medicine

Published: April 27, 2018

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.

Journal: CMAJ open

Published: March 28, 2018

Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario.

Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario.

Journal: Addiction (Abingdon, England)

Published: February 09, 2018

Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.

Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.

Journal: CMAJ open

Published: November 24, 2017

Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study.

Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study.

Journal: The British journal of dermatology

Published: September 18, 2016

Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study.

Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study.

Journal: The Australasian journal of dermatology

Published: May 02, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026